InvestorsHub Logo
Followers 48
Posts 5732
Boards Moderated 0
Alias Born 01/25/2008

Re: cazual post# 79732

Thursday, 10/23/2014 8:12:35 PM

Thursday, October 23, 2014 8:12:35 PM

Post# of 91007
Yes and its looking better for $SFVC's same day procedure with the FDA.
LJ
http://www.law360.com/articles/589697/fda-clarifies-oversight-exception-for-stem-cell-procedures
http://www.faim.org/stemcell/why-cant-we-use-our-own-stem-cells-heal-our-bodies.html

President Obama issued Executive Order 13563: A Retrospective Review "Look Back" at existing regulations. It is our belief the FDA regulation found at 21 C.F.R 1271.3 (d) is a candidate for this review. Under the Bush Administration on April 1, 2006, the FDA changed the definition of human cellular and tissue-based products from "any human tissue derived from a human body and intended for transplantation into another human...." to "(d) Human cells, tissue, or cellular or tissue-based products (HCT/Ps) means articles containing or consisting of human cells or tissues that are intended for implantation, transplantation, infusion, or transfer into a human recipient...."



Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.